Antitumor agent-185
Product Specifications
UNSPSC Description
Antitumor agent-185 (compound 3) shows antitumor activity that could effectively reduce the growth of tumors and prolong the survival time of mice in vivo[1].
Target Antigen
Others
Type
Reference compound
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/antitumor-agent-185.html
Smiles
O[C@@H]1C(O[C@@H]([C@H]([C@@H]1O)OC(C[C@@H](CCCCCCCCCCC)OC(CCCCCCCCCCC)=O)=O)COP(O)(O)=O)OC2[C@@H]([C@H]([C@@H]([C@H](O2)COCC3=CN(N=N3)CCO[C@@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O[C@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O)O)NC(C)=O)OP(O)(O)=O)OC(C[C@@H](CCCCCCCCCCC)OC(CCCCCCCCCCC)=O)=O)NC(C[C@@H](CCCCCCCCCCC)OC(CCCCCCCCCCC)=O)=O
Molecular Weight
2217.71
References & Citations
[1]Lingqiang Gao, et al. Design, Synthesis, and Bioactivity Evaluation of a TF-Based Cancer Vaccine Candidate Using Lipid A Mimetics As a Built-In Adjuvant. J Med Chem. 2024 Jun 27;67(12):9976-9990.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-163965/Antitumor-agent-185-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-163965/
Clinical Information
No Development Reported
CAS Number
9007-83-4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1434677 Inquire
Recombinant Ustilago maydis Multiple RNA-binding domain-containing protein 1 (MRD1), partial
Ask
View Details MBS6147968-01 0.1 mL
LANCL1 (LanC-like Protein 1, 40kD Erythrocyte Membrane Protein, p40, GPR69A) (FITC)
Ask
View Details MBS6147968-02 5x 0.1 mL
LANCL1 (LanC-like Protein 1, 40kD Erythrocyte Membrane Protein, p40, GPR69A) (FITC)
Ask
View Details